232 related articles for article (PubMed ID: 36052089)
1. Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.
Gomes YCP; Freitas NL; Souza FS; Sandim V; Pereira DA; Nogueira FCS; Echevarria-Lima J; Leite ACCB; Lima MASD; Silva MTT; Araújo AQC; Vicente ACP; Espíndola OM
Front Immunol; 2022; 13():949516. PubMed ID: 36052089
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
[TBL] [Abstract][Full Text] [Related]
3. An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers.
Yamauchi J; Araya N; Yagishita N; Sato T; Yamano Y
Pharmacol Ther; 2021 Feb; 218():107669. PubMed ID: 32835825
[TBL] [Abstract][Full Text] [Related]
4. Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.
Sato T; Yagishita N; Tamaki K; Inoue E; Hasegawa D; Nagasaka M; Suzuki H; Araya N; Coler-Reilly A; Hasegawa Y; Tsuboi Y; Takata A; Yamano Y
Front Microbiol; 2018; 9():1651. PubMed ID: 30090093
[TBL] [Abstract][Full Text] [Related]
5. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Sato T; Coler-Reilly A; Utsunomiya A; Araya N; Yagishita N; Ando H; Yamauchi J; Inoue E; Ueno T; Hasegawa Y; Nishioka K; Nakajima T; Jacobson S; Izumo S; Yamano Y
PLoS Negl Trop Dis; 2013; 7(10):e2479. PubMed ID: 24130912
[TBL] [Abstract][Full Text] [Related]
6. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Saito M; Tanaka R; Arishima S; Matsuzaki T; Ishihara S; Tokashiki T; Ohya Y; Takashima H; Umehara F; Izumo S; Tanaka Y
Retrovirology; 2013 May; 10():51. PubMed ID: 23651542
[TBL] [Abstract][Full Text] [Related]
8. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y; Jacobson S
Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
[TBL] [Abstract][Full Text] [Related]
10. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Tamaki K; Sato T; Tsugawa J; Fujioka S; Yagishita N; Araya N; Yamauchi J; Coler-Reilly ALG; Nagasaka M; Hasegawa Y; Yamano Y; Tsuboi Y
Front Microbiol; 2019; 10():2110. PubMed ID: 31572323
[TBL] [Abstract][Full Text] [Related]
12. Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Matsuura E; Matsuzaki T; Watanabe O; Kubota R; Izumo S; Takashima H
PLoS One; 2014; 9(5):e86144. PubMed ID: 24802839
[TBL] [Abstract][Full Text] [Related]
13. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
14. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T
Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
[TBL] [Abstract][Full Text] [Related]
17. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS
Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511
[TBL] [Abstract][Full Text] [Related]
18. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
[TBL] [Abstract][Full Text] [Related]
19. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]